The foreign body response (FBR) is the brain's immune reaction to an implanted device. Any material inserted into neural tissue triggers a complex inflammatory cascade involving microglia, astrocytes, and other immune cells. Over weeks to months, this response produces a glial scar around the implant that increases electrode impedance, pushes neurons away from recording sites, and ultimately degrades signal quality. The FBR is the primary biological challenge for chronic implanted BCIs.

Timeline

The FBR progresses through distinct phases:

  1. Acute phase (hours to days): Insertion trauma ruptures blood vessels and cell membranes. Microglia — the brain's resident immune cells — rapidly migrate to the implant site and become activated. Blood-brain barrier breach allows infiltration of blood-borne macrophages.
  2. Subacute phase (days to weeks): Activated microglia and macrophages phagocytose debris and release inflammatory cytokines (TNF-alpha, IL-1beta, IL-6). Astrocytes become reactive (hypertrophic) and begin forming a glial sheath around the implant.
  3. Chronic phase (weeks to years): A dense glial scar (astrocytic sheath) encapsulates the implant. Neurons within 50-100 micrometers of the electrode recede or die. The glial scar increases electrode impedance and acts as a diffusion barrier. This is the primary cause of recording quality degradation.

Impact on BCI

The FBR directly affects BCI performance:

  • Signal loss: As neurons recede from electrode tips, single-unit amplitudes decrease and fewer neurons are detectable
  • Impedance increase: The glial scar adds a resistive layer between the electrode and neural tissue
  • Noise increase: Inflammatory processes can increase baseline noise levels
  • Long-term instability: Signal quality may fluctuate unpredictably over months to years

In the Utah Array, typically 50-70% of initial single-unit yield is lost within the first year, though multi-unit activity and LFP signals degrade less.

Mitigation Strategies

Active research aims to reduce the FBR:

  • Flexible materials: Polymer-based electrodes (Neuralink threads, Precision thin films) that match brain tissue stiffness reduce micromotion-driven inflammation
  • Smaller electrodes: Reducing the cross-sectional area of implanted shanks decreases tissue displacement and inflammation
  • Anti-inflammatory coatings: Drug-eluting electrode coatings (dexamethasone, minocycline) suppress acute inflammation
  • Surface modifications: Bioactive coatings (L1, laminin, BDNF) that promote neuronal survival and attraction toward electrode sites